文献速递重症综合管理与镇静镇痛复苏、休克与脓毒症

输血对重症脓毒症患者死亡及其他不良事件的影响:基于边际结构Cox模型的观察性研究

Effect of Transfusion on Mortality and Other Adverse Events Among Critically Ill Septic Patients: An Observational Study Using a Marginal Structural Cox Model.
PubMed 文献 · Crit Care Med · 2017-01-01
一句话结论在重症脓毒症患者中,红细胞输血与30天死亡无显著相关(HR 1.07,95%CI 0.88-1.30),但与ICU获得性感染(HR 2.77)和严重低氧血症(HR 1.29)风险增加相关。

该研究基于法国前瞻性多中心数据库,纳入6016例入院时脓毒症患者(排除入院时失血性休克),使用边际结构Cox模型评估1天内一次或多次红细胞输血对30天死亡、ICU获得性感染和严重低氧血症的影响。结果显示,红细胞输血与死亡无显著相关(HR 1.07,95%CI 0.88-1.30,p=0.52),但与ICU获得性感染(HR 2.77,95%CI 2.33-3.28,p<0.01)和严重低氧血症(HR 1.29,95%CI 1.14-1.47,p<0.01)风险增加相关。在红细胞压积最低亚组(26,IQR 24-28)中,输血对死亡显示保护效应(HR 0.72,95%CI 0.55-0.95,p=0.02)。作者认为,红细胞输血不影响重症脓毒症患者总体死亡率,但ICU获得性感染和严重低氧血症发生率增加需与特定患者的获益权衡。

要点

  • 在6016例重症脓毒症患者中,1天内红细胞输血与30天死亡无显著相关(HR 1.07,95%CI 0.88-1.30,p=0.52)。
  • 红细胞输血与ICU获得性感染风险增加相关(HR 2.77,95%CI 2.33-3.28,p<0.01)。
  • 红细胞输血与严重低氧血症风险增加相关(HR 1.29,95%CI 1.14-1.47,p<0.01)。
  • 在红细胞压积最低亚组(26,IQR 24-28)中,输血对死亡显示保护效应(HR 0.72,95%CI 0.55-0.95,p=0.02)。
  • 作者认为,ICU获得性感染和严重低氧血症发生率增加需与特定患者的输血获益权衡。

适用人群与场景

  • 入院时脓毒症患者。
  • 排除入院时失血性休克患者。

研究设计与关键结果

  • 研究类型:观察性研究,使用边际结构Cox模型;数据来源:法国前瞻性多中心数据库;样本量:6016例脓毒症患者。
  • 主要终点:1天内一次或多次红细胞输血对30天死亡的影响,无显著相关(HR 1.07,95%CI 0.88-1.30,p=0.52)。
  • 关键次要终点:ICU获得性感染风险增加(HR 2.77,95%CI 2.33-3.28,p<0.01);严重低氧血症风险增加(HR 1.29,95%CI 1.14-1.47,p<0.01)。
  • 亚组分析:基于红细胞压积演变轨迹建模识别亚组,在红细胞压积最低亚组(26,IQR 24-28)中,输血对死亡显示保护效应(HR 0.72,95%CI 0.55-0.95,p=0.02)。

证据类型、等级与局限

  • 证据类型:观察性研究(前瞻性多中心数据库),使用边际结构Cox模型。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,红细胞输血不影响重症脓毒症患者总体死亡率,但ICU获得性感染和严重低氧血症发生率增加需与特定患者的输血获益权衡。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: RBC transfusion is often required in patients with sepsis. However, adverse events have been associated with RBC transfusion, raising safety concerns. A randomized controlled trial validated the 7 g/dL threshold, but previously transfused patients were excluded. Cohort studies led to conflicting results and did not handle time-dependent covariates and history of treatment. Additional data are thus warranted to guide patient's management.

DESIGN: To estimate the effect of one or more RBC within 1 day on three major outcomes (mortality, ICU-acquired infections, and severe hypoxemia) at day 30, we used marginal structural models. A trajectory modeling, based on hematocrit evolution pattern, allowed identification of subgroups. Secondary analyses were performed into each of them.

SETTING: A prospective French multicenter database.

PATIENTS: Patients with sepsis at admission. Patients with hemorrhagic shock at admission were excluded.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Overall, in our cohort of 6,016 patients, RBC transfusion was not associated with death (hazard ratio, 1.07; 95% CI, 0.88-1.30; p = 0.52). However, RBC transfusion was associated with increased occurrence of ICU-acquired infections (hazard ratio, 2.77; 95% CI, 2.33-3.28; p < 0.01) and of severe hypoxemia (hazard ratio, 1.29; 95% CI, 1.14-1.47; p < 0.01). A protective effect from death by the transfusion was found in the subgroup with the lowest hematocrit level (26 [interquartile range, 24-28]) (hazard ratio, 0.72; 95% CI, 0.55-0.95; p = 0.02).

CONCLUSIONS: RBC transfusion did not affect overall mortality in critically ill patients with sepsis. Increased occurrence rate of ICU-acquired infection and severe hypoxemia are expected outcomes from RBC transfusion that need to be weighted with its benefits in selected patients.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Dupuis C, Garrouste-Orgeas M, Bailly S, et al. Effect of Transfusion on Mortality and Other Adverse Events Among Critically Ill Septic Patients: An Observational Study Using a Marginal Structural Cox Model. Crit Care Med. 2017. PMID: 28906284. doi:10.1097/CCM.0000000000002688

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。